Intranasal PH94B for Management of the Symptoms of Generalized Social Phobia
Clinical trial NCT01217788 · COMPLETED
Trial details
- NCT number
- NCT01217788
- Sponsor
- Pherin Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2011-02-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.